Search Results

Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride

Authors: HOSOKAWA, Chisato; TAKEUCHI, Satoshi; FURUE, Masutaka

Source: Journal of Dermatology, Volume 36, Number 4, April 2009 , pp. 185-190(6)

Publisher: Blackwell Publishing

Use of olopatadine ophthalmic solution and reactivity of histamine skin testing

Authors: Jones, Jeremy D.; Temino, Viviana M.; Dworski, Ryszard; Anderson, Cindy K.; Fahrenholz, John M.; An, Angel Qi

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 636-639(4)

Publisher: OceanSide Publications, Inc

Effects of olopatadine in limited scleroderma with peripheral eosinophils

Authors: Kikuchi, Motoo; Inagaki, Toshiaki; Hanaki, Hidekazu; Harada, Shinsuke; Ueda, Ryuzo

Source: Geriatrics and Gerontology International, Volume 8, Number 3, September 2008 , pp. 204-208(5)

Publisher: Blackwell Publishing

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye

Authors: Mah, F.S.; O'Brien, T.; Kim, T.; Torkildsen, G.

Source: Current Medical Research and Opinion, Volume 24, Number 2, February 2008 , pp. 441-447(7)

Publisher: Informa Healthcare

Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate

Authors: Patel, Deepen; Garadi, Rekha; Brubaker, Michael; Conroy, J. Peter; Kaji, Yoshiko; Crenshaw, Krista; Whitling, Anna; Wall, G. Michael

Source: Allergy and Asthma Proceedings, Volume 28, Number 5, September-October 2007 , pp. 592-599(8)

Publisher: OceanSide Publications, Inc

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Authors: Abelson, Mark B.; Gomes, Paul J.; Pasquine, Terri; Edwards, Michael R.; Gross, Robert D.; Robertson, Stella M.

Source: Allergy and Asthma Proceedings, Volume 28, Number 4, July-August 2007 , pp. 427-433(7)

Publisher: OceanSide Publications, Inc

Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus

Authors: HASHIMOTO, Yuki; KANTO, Hiromi; ITOH, Masatoshi

Source: Journal of Dermatology, Volume 34, Number 8, August 2007 , pp. 577-582(6)

Publisher: Blackwell Publishing

Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis

Author: Berger, William E

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 7, Number 3, June 2007 , pp. 221-226(6)

Publisher: Expert Reviews

Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice

Authors: Amano, T.; Takeda, T.; Yano, H.; Tamura, T.

Source: British Journal of Dermatology, Volume 156, Number 5, May 2007 , pp. 906-912(7)

Publisher: Blackwell Publishing

Food-dependent exercise-induced anaphylaxis with a high level of plasma noradrenaline

Authors: KATO, Yukihiko; NAGAI, Ayako; SAITO, Masuyoshi; ITO, Tomonobu; KOGA, Michiyuki; TSUBOI, Ryoji

Source: Journal of Dermatology, Volume 34, Number 2, February 2007 , pp. 110-113(4)

Publisher: Blackwell Publishing

Pharmacology, clinical efficacy and safety of olopatadine hydrochloride

Authors: Lichtenstein, Steven J; Abelson, Mark B

Source: Expert Review of Clinical Immunology, Volume 2, Number 3, May 2006 , pp. 341-351(11)

Publisher: Expert Reviews

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis

Authors: Meltzer, Eli O.; Hampel, Frank C.; Ratner, Paul H.; Bernstein, David I.; Larsen, Lawrence V.; Berger, William E.; Finn, Albert F.; Marple, Bradley F.; Roland, Peter S.; Wall, G M.; Brubaker, Michael J.; Dimas, Carolyn; Potts, Susan L.; Silver, Lewis H.; Barnes, J R.o.d.

Source: Annals of Allergy, Asthma and Immunology, Volume 95, Number 6, December 2005 , pp. 600-606(7)

Publisher: American College of Allergy, Asthma, & Immunology

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar

Authors: Ratner, Paul H.; Hampel, Frank C.; Amar, Niran J.; van Bavel, Julius H.; Mohar, Dale; Marple, Bradley F.; Roland, Peter S.; Wall, G M.; Brubaker, Michael J.; Drake, Margaret; Turner, Darell; Silver, Lewis H.

Source: Annals of Allergy, Asthma and Immunology, Volume 95, Number 5, November 2005 , pp. 474-479(6)

Publisher: American College of Allergy, Asthma, & Immunology

Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy

Authors: Berger, William; Abelson, Mark B.; Gomes, Paulo J.; Beck, Morris; Kimura, Stephen; Westbrook, Thomas; Storms, William; Galant, Stanley

Source: Annals of Allergy, Asthma and Immunology, Volume 95, Number 4, October 2005 , pp. 361-371(11)

Publisher: American College of Allergy, Asthma, & Immunology

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

Authors: Abelson, Mark B.; Gomes, Paul J.; Vogelson, Cullen T.; Pasquine, Terri A.; Turner, F. Darell; Wells, David T.; Robertson, Stella M.

Source: Current Medical Research and Opinion, Volume 21, Number 5, May 2005 , pp. 683-692(10)

Publisher: Informa Healthcare

Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity

Authors: T. Tamura; M. Matsubara; K. Hasegawa; K. Ohmori; A. Karasawa

Source: Clinical & Experimental Allergy, Volume 35, Number 1, January 2005 , pp. 97-103(7)

Publisher: Blackwell Publishing

Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice

Authors: T. Tamura; M. Matsubara; C. Takada; K. Hasegawa; K. Suzuki; K. Ohmori; A. Karasawa

Source: British Journal of Dermatology, Volume 151, Number 6, December 2004 , pp. 1133-1142(10)

Publisher: Blackwell Publishing

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model

Authors: Lanier, Bobby Q.; Finegold, Ira; D'Arienzo, Peter; Granet, David; Epstein, Arthur B.; Ledgerwood, Greg L.

Source: Current Medical Research and Opinion, Volume 20, Number 8, 1 August 2004 , pp. 1227-1233(7)

Publisher: Informa Healthcare

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

Authors: Spangler D.L.; Abelson M.B.; Ober A.; Gotnes P.J.

Source: Clinical Therapeutics, Volume 25, Number 8, August 2003 , pp. 2245-2267(23)

Publisher: Elsevier

Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells

Authors: Tokura Y.; Kobayashi M.; Ito T.; Takahashi H.; Matsubara A.; Takigawa M.

Source: Cellular Immunology, Volume 224, Number 1, July 2003 , pp. 47-54(8)

Publisher: Elsevier